GT Biopharma (GTBP) Other Operating Expenses (2011 - 2026)
GT Biopharma (GTBP) posted quarterly Other Operating Expenses of -$861000.0 for Q1 2026, up 40.37% year-over-year from -$613361.6 in Q1 2025, and up 54.99% quarter-over-quarter from -$1.9 million in Q4 2025.
GT Biopharma (GTBP) Other Operating Expenses (2011 - 2026) Analysis & Trends
GT Biopharma (GTBP) has reported Other Operating Expenses for 6 consecutive years, with -$861000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 40.37% year-over-year to -$861000.0; the TTM figure through Mar 2026 stood at -$5.0 million (up 49.2% YoY), while the FY2025 annual figure was -$5.6 million, up 43.09% from the prior year.
- Other Operating Expenses advanced to -$861000.0 in Q1 2026 per GTBP's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at -$779000.0 in Q2 2025 and bottomed at -$4.4 million in Q4 2024.
- Historically, Other Operating Expenses has averaged -$1.8 million across 3 years, with a median of -$1.4 million in 2025.
- On a YoY basis, Other Operating Expenses climbed as much as 65.94% in 2025 and fell as far as 0.77% in 2025.
- GT Biopharma's Other Operating Expenses stood at -$4.4 million in 2024, then jumped by 56.6% to -$1.9 million in 2025, then soared by 54.99% to -$861000.0 in 2026.
- Business Quant data shows GTBP's Other Operating Expenses at -$861000.0 in Q1 2026, -$1.9 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -861,000.00 |
| Dec 31, 2025 | -1.91 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | -779,000.00 |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | -4.41 Mn |
| Sep 30, 2024 | -1.69 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Dec 31, 2019 | 20.49 Mn |
| Sep 30, 2019 | -20.46 Mn |
| Jun 30, 2019 | -31,000.00 |
| Dec 31, 2012 | 400,000.00 |
| Dec 31, 2011 | 420,000.00 |